A Chemical Genomics Approach to Drug Reprofiling in Oncology: Antipsychotic Drug Risperidone as a Potential Adenocarcinoma Treatment

Dilly, SJ, Clark, AJ, Marsh, A et al. (4 more authors) (2017) A Chemical Genomics Approach to Drug Reprofiling in Oncology: Antipsychotic Drug Risperidone as a Potential Adenocarcinoma Treatment. Cancer Letters, 393. pp. 16-21. ISSN 0304-3835

Abstract

Metadata

Authors/Creators:
Copyright, Publisher and Additional Information: © 2017 Published by Elsevier Ireland Ltd. This is an author produced version of a paper published in Cancer Letters. Uploaded in accordance with the publisher's self-archiving policy.
Keywords: chemical genomics; drug reprofiling; Drosophila melanogaster; 17-β-hydroxysteroid dehydrogenase 10; adenocarcinoma
Dates:
  • Published: 1 May 2017
  • Accepted: 31 January 2017
  • Published (online): 8 February 2017
Institution: The University of Leeds
Academic Units: The University of Leeds > Faculty of Maths and Physical Sciences (Leeds) > School of Chemistry (Leeds) > Organic Chemistry (Leeds)
Depositing User: Symplectic Publications
Date Deposited: 03 Feb 2017 11:53
Last Modified: 08 Feb 2018 01:38
Published Version: https://doi.org/10.1016/j.canlet.2017.01.042
Status: Published
Publisher: Elsevier
Identification Number: https://doi.org/10.1016/j.canlet.2017.01.042

Share / Export

Statistics